Thomas A. Abrams Senior Physician and Assistant Professor of Medicine at Harvard Medical School explains the next steps a patient with hepatocellular carcinoma (HCC) can do if they fail the 1st line therapy with immunocology.
Next Steps if Patient Fails 1st Line Therapy in HCC with Immunocology
